Notice of Establishment, 65050-65051 [07-5744]

Download as PDF 65050 Federal Register / Vol. 72, No. 222 / Monday, November 19, 2007 / Notices exposures, should they become pregnant. The remainder of the study population will comprise women enrolled early in pregnancy. The seven centers combined will follow approximately 1000 infants born to women enrolled in the first year of this Pilot Study. Infants born to women enrolled in this Pilot Study but born after the eligibility period for the Pilot will be eligible for enrollment in the full NCS. The schedule of participant contacts for this data collection includes home visits, clinic visits, and phone contacts, and is described in the NCS Research Plan: https:// nationalchildrensstudy.gov. Home visits before and during pregnancy will include collection of interview data, environmental specimens such as air and dust samples, maternal and paternal biospecimens such as blood and hair samples, and a brief physical examination including anthropometric measures and blood pressure. During pregnancy, women will receive up to three fetal ultrasounds to assess fetal growth. At birth, cord blood and placental samples will be collected and the infant will receive a brief developmental assessment. During infancy, home visits will include collection of interview data, environmental specimens, biospecimens from the infant and parents, a brief physical examination of the infant, and assessment of infant development and parental-infant interactions. Burden statement: The public burden for this Study will vary depending on the eligibility and pregnancy status of potential participants at the time of household screening. Women who are not pregnant at the time of screening will have varying burden depending on their likelihood of pregnancy and, should they become pregnant, the time to pregnancy. The burden for women enrolled during pregnancy will depend on when during pregnancy they are identified and enrolled in the Study. The table provides an annualized average burden per person for each stage of the Pilot Study over the three year period of the Study. ESTIMATED AVERAGE ANNUAL BURDEN FOR PILOT STUDY FOR NATIONAL CHILDREN’S STUDY, BASED ON THREE YEAR TOTALS Estimated number of responses per respondent Estimated number of respondents Types of respondents (estimated hourly rate) Household activities ($12/hr): Household enumeration ........................................................... Eligibility screening ................................................................... Preconception activities ($12/hr): High probability women ............................................................ Moderate prob, women ............................................................ Low probability women ............................................................. Pregnancy activities—women ($12/hr) ..................................... Birth activities—mothers & children ($12/hr) ............................ Postnatal activities—mothers & children ($12/hr) .................... Fathers ($12/hr) ........................................................................ Health care providers ($90/hr) .................................................. Community leaders ($75/hr) ..................................................... Child care providers ($25/hr) .................................................... Total ................................................................................... Average burden hours per response Estimated total annual burden hours 76,911 45,316 0.33 0.33 0.08 0.08 2,051 1,208 4,117 5,500 3,578 954 912 893 954 500 500 364 * 79,229 1.33 1 0.33 7 2 4 2 0.33 0.33 0.33 ............................ 1.15 0.08 0.08 0.62 0.38 0.81 0.72 0.05 0.05 1.00 ............................ 6,285 458 95 4,134 684 2,887 1,370 8 8 121 19,209 rwilkins on PROD1PC63 with NOTICES * Total number of respondents is less than the sum of the column since the mothers will be identified in the household enumeration and screening. The estimated annualized cost to respondents is $234,488 based on the differential hourly rate estimates in the above table. There are no Capital Costs to report. There are no Operating or Maintenance Costs to report. Request for Comments: Written comments and/or suggestions from the public and affected agencies are invited on one or more of the following points: (1) Whether the proposed collection of information is necessary for the proper performance of the function of the agency, including whether the information will have practical utility; (2) The accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) Ways to enhance the quality, utility, and clarity of the information to be collected; and (4) Ways to minimize the burden of the collection of information on those who VerDate Aug<31>2005 20:17 Nov 16, 2007 Jkt 214001 are to respond, including the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology. FOR FURTHER INFORMATION CONTACT: To request more information on the proposed project or to obtain a copy of the data collection plans and instruments, contact Kenneth C. Schoendorf, MD, MPH, National Institute of Child Health and Human Development, Building 6100, 5C01, 6100 Executive Blvd, Bethesda, Maryland, 20892, or call non-toll free number (301) 594–9147, or e-mail your request, including your address to ncsinfo@mail.nih.gov. Comments Due Date: Comments regarding this information collection are best assured of having their full effect if received within 60-days of the date of this publication. PO 00000 Frm 00065 Fmt 4703 Sfmt 4703 Dated: November 6, 2007. Paul Johnson, NICHD Project Clearance Liaison, National Institutes of Health. [FR Doc. E7–22597 Filed 11–16–07; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Notice of Establishment Pursuant to the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), the Director, National Institutes of Health (NIH), announces the establishment of the Emerging Neuroscience and Training Integrated Review Group. The Emerging Neuroscience and Training Integrated Review Group shall E:\FR\FM\19NON1.SGM 19NON1 Federal Register / Vol. 72, No. 222 / Monday, November 19, 2007 / Notices Dated: November 1, 2007. Elias A. Zerhouni, Director, National Institutes of Health. [FR Doc. 07–5744 Filed 11–16–07; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel, Program Project in Cardiovascular Disease. Date: December 14, 2007. Time: 9 a.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Garden Inn Washington, DC Franklin Square, 815 14th Street, NW., Washington, DC 20055. Contact Person: Holly Patton, PhD, Scientific Review Administrator, Review Branch/DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7188, Bethesda, MD 20892–7924, 301–435– 0280, patton@nhlbi.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) Institute of Environmental Health Sciences, P.O. Box 12233, MD EC–24, Research Triangle Park, NC 27709, (919) 541–1307. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.115, Biometry and Risk Estimation—Health Risks from Environmental Exposures; 93.142, NIEHS Hazardous Waste Worker Health and Safety Training; 93.143, NIEHS Superfund Hazardous Substances—Basic Research and Education; 93.894, Resources and Manpower Development in the Environmental Health Sciences; 93.113, Biological Response to Environmental Health Hazards; 93.114, Applied Toxicological Research and Testing, National Institutes of Health, HHS) Dated: November 13, 2007. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 07–5739 Filed 11–16–07; 8:45 am] BILLING CODE 4140–01–M BILLING CODE 4140–01–M provide advice and recommendations to the Director, NIH, and the Director, Center for Scientific Review (CSR), on the scientific and technical merit of applications for grants-in-aid for research, research training or researchrelated grants and cooperative agreements, or contact proposals relating to (1) the crosscutting technologies that serve all of the neurosciences, including neuroinformatics and imaging and molecular neurogenetics; (2) crosscutting emerging science in the small business area for all of the neurosciences; and (3) the training areas for all of the neurosciences. Duration of this committee is continuing unless formally determined by the Director, NIH, that termination would be in the best public interest. National Institutes of Health National Institutes of Health DEPARTMENT OF HEALTH AND HUMAN SERVICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. rwilkins on PROD1PC63 with NOTICES National Heart, Lung, and Blood Institute; Notice of Closed Meetings National Institutes of Health Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel, Clinical Trial Registry. Date: December 4, 2007. Time: 12 p.m. to 3 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Youngsuk Oh, PhD, Scientific Review Administrator, Review Branch/DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7182, Bethesda, MD 20892–7924, 301–435– 0277, yoh@mail.nih.gov. VerDate Aug<31>2005 20:17 Nov 16, 2007 Jkt 214001 65051 National Institute of Environmental Health Sciences; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Environmental Health Sciences Review Committee. Date: November 28–29, 2007. Time: 8:30 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Sheraton Chapel Hill Hotel, One Europa Drive, Chapel Hill, NC 27517. Contact Person: Linda K. Bass, PhD, Scientific Review Administrator, Nat’l PO 00000 Frm 00066 Fmt 4703 Sfmt 4703 Dated: November 9, 2007. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 07–5736 Filed 11–16–07; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institute on Aging; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Aging Special Emphasis Panel; ‘‘Prion Diseases’’ Date: December 6, 2007. Time: 1 p.m. to 4:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institute on Aging, Gateway Building, 7201 Wisconsin Avenue, 2C212, Bethesda, MD 20814, (Telephone Conference Call). Contact Person: Ramesh Vemuri, PhD, Scientific Review Office, National Institute on Aging, National Institutes of Health, 7201 Wisconsin Avenue, Suite 2C–212, Bethesda, MD 20892, 301–402–7700, rv23r@nih.gov. E:\FR\FM\19NON1.SGM 19NON1

Agencies

[Federal Register Volume 72, Number 222 (Monday, November 19, 2007)]
[Notices]
[Pages 65050-65051]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-5744]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Notice of Establishment

    Pursuant to the Federal Advisory Committee Act, as amended (5 
U.S.C. Appendix 2), the Director, National Institutes of Health (NIH), 
announces the establishment of the Emerging Neuroscience and Training 
Integrated Review Group.
    The Emerging Neuroscience and Training Integrated Review Group 
shall

[[Page 65051]]

provide advice and recommendations to the Director, NIH, and the 
Director, Center for Scientific Review (CSR), on the scientific and 
technical merit of applications for grants-in-aid for research, 
research training or research-related grants and cooperative 
agreements, or contact proposals relating to (1) the crosscutting 
technologies that serve all of the neurosciences, including 
neuroinformatics and imaging and molecular neurogenetics; (2) 
crosscutting emerging science in the small business area for all of the 
neurosciences; and (3) the training areas for all of the neurosciences.
    Duration of this committee is continuing unless formally determined 
by the Director, NIH, that termination would be in the best public 
interest.

    Dated: November 1, 2007.
Elias A. Zerhouni,
Director, National Institutes of Health.
[FR Doc. 07-5744 Filed 11-16-07; 8:45 am]
BILLING CODE 4140-01-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.